Cargando…

Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma

OBJECTIVE: There is no effective and reliable biomarker to distinguish benign thyroid nodules from papillary thyroid carcinomas (PTC). This study aimed at examining the levels of plasma miRNAs in patients with PTC or benign nodules to explore the potential miRNA biomarkers for PTC. PATIENTS AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Min, Song, Qinbin, Li, Hang, Lou, Yi, Wang, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500410/ https://www.ncbi.nlm.nih.gov/pubmed/26168287 http://dx.doi.org/10.1371/journal.pone.0132403

Ejemplares similares

Correction: Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma
por: Li, Min, et al.
Publicado: (2015)

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
por: Redova, Martina, et al.
Publicado: (2012)

Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients
por: Besharat, Z. M., et al.
Publicado: (2023)

miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC
por: Gao, Bo, et al.
Publicado: (2023)

Serum miR-22 may be a biomarker for papillary thyroid cancer
por: Wang, Deping, et al.
Publicado: (2019)

Orange Juice Attenuates Circulating miR-150-5p, miR-25-3p, and miR-451a in Healthy Smokers: A Randomized Crossover Study
por: Dorna, Mariana S., et al.
Publicado: (2021)

miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma
por: Minna, Emanuela, et al.
Publicado: (2016)

Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer
por: Du, Yu, et al.
Publicado: (2022)

Reciprocal Dysregulation of MiR-146b and MiR-451 Contributes in Malignant Phenotype of Follicular Thyroid Tumor
por: Knyazeva, Margarita, et al.
Publicado: (2020)

Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023)

Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma
por: Minna, Emanuela, et al.
Publicado: (2018)

CSDE1 promotes miR-451 biogenesis
por: Kakumani, Pavan Kumar, et al.
Publicado: (2023)

Plasma Level Of miR-21 And miR-451 In Primary And Recurrent Breast Cancer Patients
por: Motamedi, Maryam, et al.
Publicado: (2019)

miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma
por: Qiu, Zhenwei, et al.
Publicado: (2017)

The Relationship and Expression of miR-451a, miR-25-3p and PTEN in Early Peritoneal Endometriotic Lesions and Their Modulation In Vitro
por: Nothnick, Warren B., et al.
Publicado: (2022)

NF‐κB inhibition reverses acidic bile‐induced miR‐21, miR‐155, miR‐192, miR‐34a, miR‐375 and miR‐451a deregulations in human hypopharyngeal cells
por: Doukas, Sotirios G., et al.
Publicado: (2018)

miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer
por: Bai, Hua, et al.
Publicado: (2019)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

The miR-144/451 locus is required for erythroid homeostasis
por: Rasmussen, Kasper D., et al.
Publicado: (2010)

Response to energy depletion: miR-451/AMPK loop
por: Bronisz, Agnieszka, et al.
Publicado: (2015)

MiR-451 as a new tumor marker for gastric cancer
por: Shen, Yong, et al.
Publicado: (2017)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
por: Nemecz, Miruna, et al.
Publicado: (2023)

Circulating miR-451a levels as a potential biomarker to predict the prognosis of patients with multiple myeloma
por: Zhong, Ling, et al.
Publicado: (2020)

miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma
por: Ivo D’Urso, Pietro, et al.
Publicado: (2015)

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans
por: Long, Guangwen, et al.
Publicado: (2013)

MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer
por: Dai, Lei, et al.
Publicado: (2017)

ssc-miR-451 Regulates Porcine Primary Adipocyte Differentiation by Targeting ACACA
por: Gan, Mailin, et al.
Publicado: (2020)

Simultaneous regulation of miR-451 and miR-191 led to erythroid fate decision of mouse embryonic stem cell
por: Shokri, Gelareh, et al.
Publicado: (2019)

Detection of miR-1246, miR-23a and miR-451 in sera of colorectal carcinoma patients: a case-control study in Cairo University hospital
por: Salah, Mona, et al.
Publicado: (2020)

Correction: MiR-451 as a new tumor marker for gastric cancer
por: Shen, Yong, et al.
Publicado: (2019)

Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer
por: Torbati, Peyman Mohammadi, et al.
Publicado: (2019)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
por: Lu, Pan, et al.
Publicado: (2017)

miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice
por: Li, Jun, et al.
Publicado: (2019)

Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
por: Shen, Jie, et al.
Publicado: (2014)

Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia
por: Elhamamsy, Amr Rafat, et al.
Publicado: (2017)

Serological profiling reveals hsa-miR-451a as a possible biomarker of anaphylaxis
por: Francuzik, Wojciech, et al.
Publicado: (2022)

Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
por: Wang, Wenrui, et al.
Publicado: (2017)

Expression of miR-127, miR-154, and miR-183 in Medullary Thyroid Carcinoma Tumors
por: RAHMANI SAMANI, Mahsa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0i08jhsolq41kd2ppgeakutvel